Molica, S., Allsup, D., Chiarenza, A., Giannarelli, D. (2025). Upfront continuous BTK inhibitor (BTKi) versus time-limited venetoclax-BTKi combinations in CLL across IGHV subgroups: Results of an indirect analysis. Blood. https://doi.org/10.1182/blood-2025-3887